Biomedicine News and Research

RSS

Researchers discover biochemical agent responsible for blood pressure drop in sepsis

A study conducted by an international group of researchers has overturned the understanding of life-threatening inflammatory diseases such as sepsis, pointing to a biochemical agent that may be involved in the rapid decline in blood pressure that occurs in the advanced stage of sepsis and usually causes the patient's death. This discovery could pave the way for novel therapeutic approaches.

14 May 2019

Biophysicists study structure of KR2 rhodopsin under physiological conditions

A team of biophysicists from Russia, Germany, and France, featuring researchers from the Moscow Institute of Physics and Technology, has discovered and studied the structure of the KR2 rhodopsin under physiological conditions.

8 May 2019

Scientists unravel mechanism of action of antitumor drug used to treat glioblastoma

Glioblastoma is an incurable type of brain tumor that is frequently associated with mutations in the epidermal growth factor receptor.

3 May 2019

Graphene can purify water, making it drinkable without further chlorination

Scientists from the National University of Science and Technology "MISIS" together with their colleagues from Derzhavin Tambov State University and Saratov Chernyshevsky State University have figured out that graphene is capable of purifying water, making it drinkable, without further chlorination.

30 Apr 2019

Researchers are developing brand-new method to cure brain tumors

Scientists from Far Eastern Federal University in cooperation with colleagues from Blokhin Russian Cancer Research Center, Switzerland, and Sweden for the first time studied proteins, which constitute WNT signaling pathway of the cancer stem cells of glioblastoma multiforme (GBM CD133+ CSCs), one of the most aggressive brain tumors.

22 Apr 2019

Precision-guided anticancer nanoparticles help enhance treatment of peritoneal tumors

Research carried out at the University of Tartu Faculty of Medicine used nanoparticles for the development of new imaging and treatment methods for peritoneal cancers. Tests showed that precision-guided anticancer nanoparticles have improved efficacy and reduced side effects.

22 Apr 2019

Two new epigenetic regulators maintain self-renewal of embryonic stem cells

Embryonic stem cells have the ability to self-renew, and, being pluripotent have the potential to create almost any cell type in the body.

19 Apr 2019

Geneva Exhibition committee gives gold medals to two medications developed by Kazan

The compounds are among the eight prospective medications developed by Kazan University's Pharmaceutics Center.

17 Apr 2019

Study uncovers new biomarker for personalized cancer treatments

Cancer cells are characterized by the ability to evade apoptosis, a type of programmed cell death that allows the organism to remove damaged cells.

16 Apr 2019

Precise decoding of breast cancer cells paves way for new treatment option

Researchers at the University of Zurich and from IBM Research have investigated the varying composition of cancer and immune cells in over one hundred breast tumors.

16 Apr 2019

Using slime mold to produce accessible biosensors

An EU-funded project is using slime mold to produce accessible sensing devices with a wide range of applications, including environmental monitoring and health - helping European industry become more competitive in the growing biosensor device market.

15 Apr 2019

New molecule could help fight type 2 diabetes and non-alcoholic fatty liver disease

A new molecule -EPB-53-, could help fight type 2 diabetes and the non-alcoholic fatty liver disease, according to a new study led by the team of Manuel Vázquez-Carrera, from the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine of the University of Barcelona, and the Diabetes and Associated Metabolic Diseases Networking Biomedical Research Center.

10 Apr 2019

Single-cell sequencing sheds light on landscape of myeloid cells in lung tumors

The recent emergence of immunotherapy has marked a sea change in research and care for many forms of cancer, bringing new hope to patients and families around the world. For those who respond to treatment, the results can be dramatic.

10 Apr 2019

Biologists analyze available methods of targeted drug delivery to malignant tumors

A team of biologists from Sechenov First Moscow State Medical University and Lobachevsky University analyzed available methods of targeted drug delivery to malignant tumors.

9 Apr 2019

Embryo selection for IVF can be optimized using artificial intelligence technique

A new artificial intelligence approach by Weill Cornell Medicine investigators can identify with a great degree of accuracy whether a 5-day-old, in vitro fertilized human embryo has a high potential to progress to a successful pregnancy.

5 Apr 2019

ETH researchers take major step towards personalized cancer immunotherapy

Cells belonging to the body's own immune system can help fight tumours. For several years now, this has allowed oncologists to use medications known as checkpoint inhibitors to encourage T cells to eliminate tumor cells.

30 Mar 2019

New medication increases muscle and bone mass in mice

It is common knowledge that as people grow older they lose a large part of their muscle mass - and neither are their bones what they once were. Researchers from Aarhus University, Denmark, working together with researchers at Erasmus Medical Center in Rotterdam have now studied a new group of medication which could prove beneficial for the elderly and the chronically ill who suffer a loss of bone- and muscle mass.

28 Mar 2019

Scientists identify five most promising application areas for magnetoresistive sensors

Excluding the information recording and reading technology, in the next 15-20 years, the hypersensitive sensors operating under the magnetoresistive principle will be applied in an extensive number of innovative areas.

22 Mar 2019

Role of immunological imprinting in elicitation of new antibodies

We are repeatedly exposed to the influenza virus via infections, vaccinations and our communal environments. The annual flu shot is believed to be the best line of defense, and doctors recommend vaccinations every year because the flu virus is in a constant state of adaptation and mutation, rendering older vaccines obsolete.

21 Mar 2019

Latest advances and perspectives of all AI types used in pharmaceutical R&D

The advances in Artificial intelligence have successfully propagated into the many areas such as computer vision, speech recognition, and natural language processing.

19 Mar 2019